It is important to investigate how both classical pathways, such as GPX4/ACSL4 ferroptosis signaling, and non-classical pathways, like GPX4-independent ferroptosis, influence breast cancer progression, invasion, and metastasis. The gene discussed is ACSL4; the disease is breast cancer.